Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    16754836 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Nicotinic Receptors and Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: DMXB-A-SR;   Other: Placebo
2 Unknown  Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia
Condition: Cognitive Impairment Associated With Schizophrenia
Interventions: Drug: MEM 3454;   Drug: Placebo for MEM 3454
3 Unknown  A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients
Condition: Schizophrenia
Interventions: Drug: MEM 3454;   Drug: Placebo for MEM 3454
4 Completed
Has Results
Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Galantamine;   Drug: CDP-choline;   Drug: Placebo;   Drug: risperidone, olanzapine, quetiapine, ziprasidone, and/or aripiprazole

Study has passed its completion date and status has not been verified in more than two years.